Dr. Atsushi Sakuraba, MD

Dr. Sakuraba practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Sakuraba's NPI, 1366756140, was assigned on August 4, 2010. Dr. Sakuraba graduated from Keio Gujuku University School of Medicine in 1997. Dr. Sakuraba holds Illinois license 036131336.

Dr. Sakuraba's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Sakuraba's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Sakuraba is also affiliated with University of Chicago Medical Center. The medical group on file is Rush University Internists. Dmand AI also links Dr. Sakuraba to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sakuraba practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Sakuraba's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Sakuraba is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sakuraba's licenses on file in 3 states: Illinois, Indiana and Texas.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, intestinal or bowel obstruction and upper GI endoscopy among the conditions Dr. Sakuraba treats.

CMS data shows 160 Medicare services from Dr. Sakuraba across 6 procedure codes in 2024, for 160 Medicare patients. Medicare paid $19,616 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Sakuraba in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sakuraba's median patient age at 58, with 55% women.

In 2024, Dr. Sakuraba wrote 299 Medicare Part D claims for 128 patients. 61% of them were for generic drugs. CMS names the drug for 150 of them, across 7 drugs with 11 or more claims each, at $1,065,442 in total drug cost. In 2023, CMS named 119 claims across 7 drugs.

Dr. Sakuraba accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of colonoscopy by Dr. Sakuraba, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 133 papers to Dr. Sakuraba, published from 2007 to 2025. 2020 was the busiest year, with 23. The most frequent topics are Colitis, Ulcerative, Inflammatory Bowel Diseases and Crohn Disease. Dr. Sakuraba has published most often in Inflamm Bowel Dis. Dr. Sakuraba's most frequent co-authors are Dejan Micic, Shintaro Akiyama, MD and Neil H. Hyman.

Dmand AI links Dr. Sakuraba to 1 clinical trial. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases.

CMS Open Payments shows 22 general payments to Dr. Sakuraba from 6 drug and device companies from 2016 to 2023. Gifts make up the largest share, 78% of the total. FUJIFILM Healthcare Americas Corporation paid the most, $76,169. It also lists 1 research payment totaling $32,500 in 2020.

Dmand AI lists 1 award for Dr. Sakuraba, most recently CMS Stage 1 EHR in 2013.

Dr. Sakuraba graduated from Keio Gujuku University School of Medicine in 1997.

Dr. Sakuraba is in network with 14 carriers, including Aetna, Elevance and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.